Donald Darkin - ResMed Insider

ResMed Inc -- USA Stock  

USD 87.51  1.17  1.32%

President ? innovation & operations

Mr. Don Darkin is President innovation operations of Resmed Inc. Previously, Mr. Darkin was president, sleepdisordered breathing strategic business unit, a position he began in May 2011, and senior vice president, strategic business unit patient interfaces from July 2007 to May 2011. Before these positions, Mr. Darkin held several senior roles within ResMed. He joined ResMed in August 1999 as vice president, product development. In May 2005, he became director of operations in France for ventilation, and subsequently served as vice president, business divisions, and senior vice president, global product development. Before working at ResMed, Mr. Darkin served as vice president of operations for Ambri Pty Ltd., Australia, and vice president, product development for Telectronics Medical Systems Australia and US. Mr. Darkin is identified as an inventor or coinventor on over 80 granted patents worldwide. Mr. Darkin was educated in the UK in mechanical engineering and has further professional management training from University of New South Wales and Massachusetts Institute of Technology.
Age: 61  President Since 2014      
858 836-5000  www.resmed.com

Management Efficiency

The company has Return on Asset of 8.72 % which means that on every $100 spent on asset it made $8.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.43 % implying that it generated $18.43 on every 100 dollars invested.
The company has 1.02 B in debt with debt to equity (D/E) ratio of 49.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed Inc has Current Ratio of 4.63 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Jeffrey MoyDexCom Inc
2011
Maureen MacInnisDENTSPLY SIRONA Inc
2016
Patrick MurphyDexCom Inc
2016
Jonathan FriedmanDENTSPLY SIRONA Inc
2016
Everett CunninghamQuest Diagnostics Incorporated
2012
Karen PrangeBoston Scientific Corporation
2012
Jeffrey MirvissBoston Scientific Corporation
2013
John SorensonBoston Scientific Corporation
2014
Keith DawkinsBoston Scientific Corporation
2012
Nicholas AlexosDENTSPLY SIRONA Inc
2017
Richard DoubledayDexCom Inc
2015
Jake LeachDexCom Inc
2015
Wendy CarruthersBoston Scientific Corporation
2012
Deborah RasinDENTSPLY SIRONA Inc
2011
Arthur ButcherBoston Scientific Corporation
2016
Edward MackeyBoston Scientific Corporation
2015
Andrew BaloDexCom Inc
2015
Maulik NanavatyBoston Scientific Corporation
2011
Donald AbbeyDexCom Inc
2017
Jon CohenQuest Diagnostics Incorporated
2013
Carrie MannerQuest Diagnostics Incorporated
2017

Entity Summary

ResMed Inc. designs, develops, manufactures, and markets medical devices and cloudbased software applications that diagnose, treat, and manage respiratory disorders. ResMed Inc (RMD) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 5,250 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ResMed Inc to your portfolio

Top Management

ResMed Inc Leadership Team
John Wareham, Director, MBA
Ronald Taylor, Director
Gary Pace, Director, Ph.D
Agnes Lee, Director
Carol Burt, Director
Rich Sulpizio, Director
Peter Farrell, Chairman, Ph.D
Jim Hollingshead, President, Ph.D
Don Darkin, President
Jack Wareham, Director
Anne Reiser, President
Karen Drexler, Director
Richard McHale, President
Donald Darkin, President
Rob Douglas, President
Christopher Roberts, Director, MBA
Chris Roberts, Director, MBA
Robert Douglas, COO
BE Farrell, Chairman
Brett Sandercock, CFO
Ron Taylor, Director
Raj Sodhi, President, MBA
David Pendarvis, Executive
Richard Sulpizio, Director
Michael Farrell, CEO, MBA

Stock Performance

ResMed Performance Indicators